Cytori Therapeutics, Inc. (CYTX)
NCM · Common · CUSIP 23283K204
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CYTX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
23283K204
Market Cap
Mid Cap · $532 Million
Business: Cytori Therapeutics, Inc. is a biotechnology company involved in the development of treatments and devices for a range of disorders using cells as a key part of the therapy. The Company is engaged in developing primary product, Cytori Cell Therapy, for patients with scleroderma hand dysfunction, orthopedic disorders, cardiovascular disease, urinary incontinence and thermal burns combined with radiation injury.
Notes: May 12, 2016 -- Cytori Therapeutics, Inc. (CYTX) will effect a one-for-fifteen (1-15) reverse split of its common stock. and the CUSIP number will change to 23283K204.

Company Contact

CEO
Marc H. Hedrick M.D.
CFO
Tiago Girao
Headquarters
3020 Callan Road, San Diego, CA 92121
Phone
858-458-0900
Investor Relations
Tiago Girao · 858-458-0900 · ir@cytori.com
General Email
info@cytori.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »